Fingerprint
Dive into the research topics of 'A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B
Man Fung Yuen*, Chi Yi Chen, Chun Jen Liu, Wen Juei Jeng, Magdy Elkhashab, Carla S. Coffin, Won Kim, Susan Greenbloom, Alnoor Ramji, Young S. Lim, Yoon J. Kim, Scott K. Fung, Dong J. Kim, Jeong Won Jang, Kwan Sik Lee, Radhakrishnan P. Iyer, Chelsea Macfarlane, Kathy Jackson, Stephen A. Locarnini, Henry L.Y. Chan
*Corresponding author for this work
- The University of Hong Kong
- Chia-Yi Christian Hospital
- National Taiwan University
- University of Toronto
- University of Calgary
- Seoul National University
- Toronto Digestive Disease Associates
- Gastrointestinal Research Institute
- University of Ulsan
- Toronto General Hospital
- Hallym University
- The Catholic University of Korea
- Yonsei University
- Inc.
- Spring Bank Pharmaceuticals
- Royal Melbourne Hospital
- Chinese University of Hong Kong
- Beth Israel Deaconess Medical Center
Research output: Contribution to journal › Journal Article › peer-review
13
Scopus
citations